Analgesic therapy and Hepatitis cholestatic

Summary:

Hepatitis cholestatic is found among people with Analgesic therapy, especially for people who are male, 60+ old.

The study analyzes which people have Hepatitis cholestatic with Analgesic therapy. It is created by eHealthMe based on reports of 14 people who have Analgesic therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Analgesic therapy?

Analgesic therapy is found to be associated with 84 drugs and 116 conditions by eHealthMe. Check the latest studies of Analgesic therapy.

What is Hepatitis cholestatic?

Hepatitis cholestatic (flow of bile from the liver is slowed or blocked) is found to be associated with 544 drugs and 824 conditions by eHealthMe. Check the latest studies of Hepatitis cholestatic.



On Jul, 28, 2026

14 people who have Analgesic Therapy and Hepatitis Cholestatic are studied.

Would you have Hepatitis cholestatic when you have Analgesic therapy?

Gender of people who have Analgesic Therapy and experienced Hepatitis Cholestatic *:

  • female: 28.57 %
  • male: 71.43 %

Age of people who have Analgesic Therapy and experienced Hepatitis Cholestatic *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 7.69 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 92.31 %

Common co-existing conditions for these people *:

  1. Pain: 2 people, 14.29%
  2. Nausea (feeling of having an urge to vomit): 2 people, 14.29%
  3. Local Anaesthesia: 2 people, 14.29%
  4. High Blood Pressure: 2 people, 14.29%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.14%
  6. Mucosal Inflammation (infection of mucous membrane): 1 person, 7.14%
  7. Joint Pain: 1 person, 7.14%
  8. Infection: 1 person, 7.14%
  9. Gastrointestinal Infection (infection of stomach and intestine): 1 person, 7.14%
  10. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 7.14%

Common drugs taken by these people *:

  1. Paracetamol: 9 people, 64.29%
  2. Gabapentin: 6 people, 42.86%
  3. Zofran: 2 people, 14.29%
  4. Morphine: 2 people, 14.29%
  5. Cardura: 2 people, 14.29%
  6. Cefazolin: 2 people, 14.29%
  7. Colace: 2 people, 14.29%
  8. Ibuprofen: 2 people, 14.29%
  9. Ambien: 2 people, 14.29%
  10. Tylox: 2 people, 14.29%

Common symptoms for these people *:

  1. Hepatotoxicity (chemical-driven liver damage): 7 people, 50.00%
  2. Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 6 people, 42.86%
  3. Septic Shock (shock due to blood infection): 2 people, 14.29%
  4. Acute Kidney Failure: 2 people, 14.29%
  5. Liver Injury: 2 people, 14.29%
  6. Hepatic Function Abnormal: 1 person, 7.14%
  7. Abdominal Tenderness: 1 person, 7.14%
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 7.14%
  9. Cholecystitis Chronic (long lasting infection of gallbladder): 1 person, 7.14%
  10. Diarrhea: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hepatitis cholestatic?

- Check whether Hepatitis cholestatic is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hepatitis cholestatic:

All the conditions that are associated with Hepatitis cholestatic:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hepatitis cholestatic and Analgesic therapy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: